JOHN V CAPPELLO
Physician in Norristown, PA
License number
Pennsylvania OS004190L
Category
Osteopathic Medicine
Type
Osteopathic Physician and Surgeon
Address
Address
Norristown, PA 19406
Personal information
See more information about JOHN V CAPPELLO at radaris.comName
Address
Phone
301 Jeffrey Ln, Newtown Square, PA 19073
6 Boxwood Ln, Langhorne, PA 19047
1616 S Glenside Rd, West Chester, PA 19380
1411 Valley Dr, West Chester, PA 19382
1312 Dill Rd, Havertown, PA 19083
Professional information
See more information about JOHN V CAPPELLO at trustoria.com
Herbal Enhanced Analgesic Formulations
Herbal Enhanced Analgesic Formulations
US Patent:
2011002, Feb 3, 2011
Filed:
Aug 3, 2010
Appl. No.:
12/804972
Inventors:
John V. Cappello - King of Prussia PA, US
Lawrence Durst - Philadelphia PA, US
Lawrence Durst - Philadelphia PA, US
International Classification:
A61K 31/7034, A61P 25/04
US Classification:
514 25
Abstract:
The analgesic properties of L-tryptophan and 5-HTP can be safely enhanced with the coadministration of salacin. Salacin can be effectively provided in the form of white willow bark along with other ingredients to further enhance the formulation's analgesic effect. As salacin can cause the loss of vitamin C in humans, the formulation advantageously includes a supplemental amount of vitamin C.
Formulations For Promoting Stem Cell Nutrition
Formulations For Promoting Stem Cell Nutrition
US Patent:
8334131, Dec 18, 2012
Filed:
Mar 21, 2012
Appl. No.:
13/425563
Inventors:
John V. Cappello - King of Prussia PA, US
International Classification:
C12N 1/12, A61K 36/02
US Classification:
4352571, 42419517
Abstract:
A a multivitamin and mineral dietary supplement includes a base composition of whole aphanizomenon flos-aqua, phycocyanin and phenylethylamine for promoting the body's natural production of stem cells. The production, support and maintenance of these stem cells is enhanced with vitamins and/or minerals. The vitamins and minerals when combined with the base composition promote good health, body repair and longevity.
Dietary Supplements Including Ellagitannins And Ellagic Acid
Dietary Supplements Including Ellagitannins And Ellagic Acid
US Patent:
2013020, Aug 8, 2013
Filed:
Feb 2, 2013
Appl. No.:
13/757744
Inventors:
John V. Cappello - King of Prussia PA, US
International Classification:
A61K 36/05, A61K 45/06, A61K 36/03, A61K 31/352, A61K 31/137
US Classification:
42419517, 514 55, 514453, 514654
Abstract:
A dietary supplement containing a source of ellagic acid, such as black raspberry seed powder, is combined with one or more of blue green algae, brown seaweed, phycocyanin and phenylathylemine. Additions of one or more vitamins and/or one or more minerals further improves the health enhancing benefits of the dietary supplement.
Compositions For Producing Satiety
Compositions For Producing Satiety
US Patent:
2010015, Jun 17, 2010
Filed:
Feb 22, 2010
Appl. No.:
12/710161
Inventors:
John V. Cappello - King of Prussia PA, US
International Classification:
A61K 36/22, A61K 31/403, A61K 35/74, A61P 3/04
US Classification:
424725, 514419, 424780
Abstract:
Long term weight loss can be achieved and maintained with a formulation of over-the-counter life-enhancing dietary supplements. One or more supplements stimulate the release of serotonin within the brain and one or more supplements stimulate the release of cholecystokinin into the bloodstream. The combined potentiating effect of these two mechanisms on satiety enables greater weight loss than that previously achieved by the individual mechanisms acting alone. A third weight loss mechanism can be achieved with the addition of phenylethylamine. Even more effective weight loss formulations can be achieved with the addition of a blue-green algae, such as aphanizomenon flos aqua, to provide a longer lasting weight loss mechanism.
Anti-Aging Formulations
Anti-Aging Formulations
US Patent:
2012025, Oct 4, 2012
Filed:
Jan 24, 2012
Appl. No.:
13/357280
Inventors:
John V. Cappello - King of Prussia PA, US
International Classification:
A61K 35/74, A61P 43/00, A61K 36/481
US Classification:
424 934
Abstract:
A dietary supplement based on blue green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside IV, vitamin D3, vitamin C, anhydrous trimethylglycine and brewer's yeast to stimulate stem cell production and reduce the rate of telomere reduction or shortening. This can result in the repair of existing body cells and enhance longevity by stimulating the production of new stem cells and maintaining the telomeres on new stem cells as well as existing cells. The dietary supplement supports an increased life span by enhancing metabolic function, activating SIRT-1 anti-aging genes, and encouraging the production of new cells with longer telomeres.
Anti-Aging Formulations
Anti-Aging Formulations
US Patent:
2013011, May 9, 2013
Filed:
Dec 21, 2012
Appl. No.:
13/723503
Inventors:
John V. Cappello - King of Prussia PA, US
International Classification:
A61K 38/16, A61K 35/74, A61K 31/137, A61K 31/12, A61K 31/357, A61K 31/715, A61K 36/481, A61K 31/4172, A61K 31/593, A61K 31/375, A61K 31/223, A61K 31/737, A61K 31/05
US Classification:
424 934, 514 187, 424 9351
Abstract:
A dietary supplement based on fucoidan, blue-green algae, phycocyanin and phenylethylamine is fortified with one or more of curcumin, silymarin, resveratrol, astragalus root extract, astragoloside IV, vitamin D3, vitamin C, anhydrous trimethylglycine and brewers yeast to stimulate stem cell production and reduce the rate of telomere reduction or shortening. This can result in the repair of existing body cells and enhance longevity by stimulating the production of new stem cells and maintaining the telomeres on new stem cells as well as existing cells. The dietary supplement supports an increased life span by enhancing metabolic function, activating SIRT-1 anti-aging genes, and encouraging the production of new cells with longer telomeres.
Topical And Transdermal Treatments Using Urea Formulation
Topical And Transdermal Treatments Using Urea Formulation
US Patent:
7803357, Sep 28, 2010
Filed:
Nov 3, 2008
Appl. No.:
12/290744
Inventors:
John V Cappello - King of Prussia PA, US
International Classification:
A01N 61/00, A61Q 9/00
US Classification:
424 701, 514 1, 514880
Abstract:
Various medical conditions, some previously treated by injection or surgery, are effectively treated by a topical application of a composition of urea and a chemotherapeutic agent. Such agents include sclerosing agents, vasodilators, botulinum toxin and minoxidil. Conditions as diverse as spider veins, erectile dysfunction, facial wrinkles, hair loss and baldness can be effectively treated with the compositions.